Chitosan-Based Nano Systems for Natural Antioxidants in Breast Cancer Therapy

被引:21
|
作者
Herdiana, Yedi [1 ]
Husni, Patihul [1 ]
Nurhasanah, Siti [2 ]
Shamsuddin, Shaharum [3 ,4 ,5 ]
Wathoni, Nasrul [1 ]
机构
[1] Univ Padjadjaran, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, Sumedang 45363, Indonesia
[2] Univ Padjadjaran, Fac Agr Ind Technol, Sumedang 45363, Indonesia
[3] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian 16150, Malaysia
[4] Univ Sains Malaysia, Inst Res Mol Med INFORMM, Nanobiotech Res Initiat, George Town 11800, Malaysia
[5] Univ Sains Malaysia, USM RIKEN Interdisciplinary Collaborat Adv Sci URI, George Town 11800, Malaysia
关键词
breast cancer; bioavailability; chitosan; oral drug delivery; pharmacokinetic; pharmacodynamic properties; OXIDATIVE STRESS; DRUG-DELIVERY; NANOPARTICLES; PHARMACOKINETICS; STRATEGIES; STABILITY; BIODEGRADATION; CHEMOTHERAPY; ENHANCE;
D O I
10.3390/polym15132953
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Breast cancer is a major cause of death globally, accounting for around 13% of all deaths. Chemotherapy, the common treatment for cancer, can have side effects that lead to the production of reactive oxygen species (ROS) and an increase in oxidative stress in the body. Antioxidants are important for maintaining the health of cells and helping the immune system function properly. They play a crucial role in balancing the body's internal environment. Using natural antioxidants is an alternative to mitigate the harmful effects of oxidative stress. However, around 80% of natural antioxidants have limited effectiveness when taken orally because they do not dissolve well in water or other solvents. This poor solubility affects their ability to be absorbed by the body and limits their bioavailability. One strategy that has been considered is to increase their water solubility to increase their oral bioavailability. Chitosan-based nanoparticle (CSNP) systems have been extensively explored due to their reliability and simpler synthesis routes. This review focuses on the various methods of chitosan-based nanoformulation for developing effective oral dosage forms for natural antioxidants based on the pharmacokinetics and pharmacodynamics properties. Chitosan (CS) could be a model, because of its wide use in polymeric NPs research, thus providing a better understanding of the role of vehicles that carry natural antioxidants in maintaining the stability and enhancing the performance of cancer drugs.
引用
收藏
页数:28
相关论文
共 50 条
  • [1] Chitosan-Based Nanoparticles in Cancer Therapy
    Lakshmanan, Vinoth-Kumar
    Snima, K. S.
    Bumgardner, Joel D.
    Nair, Shantikumar V.
    Jayakumar, Rangasamy
    CHITOSAN FOR BIOMATERIALS I, 2011, 243 : 55 - 91
  • [2] Overview of chitosan-based nanosystems for prostate cancer therapy
    de Araujo, Jennifer Thayanne Cavalcante
    Tavares Junior, Alberto Gomes
    Di Filippo, Leonardo Delello
    Duarte, Jonatas Lobato
    Ribeiro, Tais de Cassia
    Chorilli, Marlus
    EUROPEAN POLYMER JOURNAL, 2021, 160
  • [3] Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy
    Herdiana, Yedi
    Wathoni, Nasrul
    Gozali, Dolih
    Shamsuddin, Shaharum
    Muchtaridi, Muchtaridi
    PHARMACEUTICS, 2023, 15 (03)
  • [4] Chitosan-based nanodelivery systems for cancer therapy: Recent advances
    Narmani, Asghar
    Jafari, Seid Mahdi
    CARBOHYDRATE POLYMERS, 2021, 272
  • [5] Chitosan-Based Theranostics for Cancer Therapy
    Soubhagya, A. S.
    Prabaharan, M.
    CHITOSAN FOR BIOMATERIALS IV: BIOMEDICAL APPLICATIONS, 2021, 288 : 271 - 292
  • [6] Nano and rnicroparticulate chitosan-based systems for antiviral topical delivery
    Calderon, L.
    Harris, R.
    Cordoba-Diaz, M.
    Elorza, M.
    Elorza, B.
    Lenoir, J.
    Adriaens, E.
    Remon, J. P.
    Heras, A.
    Cordoba-Diaz, D.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (1-2) : 216 - 222
  • [7] Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy
    Ashrafizadeh, Milad
    Hushmandi, Kiavash
    Mirzaei, Sepideh
    Bokaie, Saied
    Bigham, Ashkan
    Makvandi, Pooyan
    Rabiee, Navid
    Thakur, Vijay Kumar
    Kumar, Alan Prem
    Sharifi, Esmaeel
    Varma, Rajender S.
    Aref, Amir Reza
    Wojnilowicz, Marcin
    Zarrabi, Ali
    Karimi-Maleh, Hassan
    Voelcker, Nicolas H.
    Mostafavi, Ebrahim
    Orive, Gorka
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2023, 8 (01)
  • [8] Chitosan-based delivery systems for mucosal vaccines
    Jabbal-Gill, Inderjit
    Watts, Peter
    Smith, Alan
    EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (09) : 1051 - 1067
  • [9] Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy
    Rhee, Jin-Kyu
    Park, Ok Kyu
    Lee, Aeju
    Yang, Dae Hyeok
    Park, Kyeongsoon
    MARINE DRUGS, 2014, 12 (12): : 6038 - 6057
  • [10] The Role of Inhaled Chitosan-Based Nanoparticles in Lung Cancer Therapy
    Silva, Allana Carvalho
    Costa, Mirsiane Pascoal
    Zacaron, Thiago Medeiros
    Ferreira, Kezia Cristine Barbosa
    Braz, Wilson Rodrigues
    Fabri, Rodrigo Luiz
    Frezard, Frederic Jean Georges
    Pittella, Frederico
    Tavares, Guilherme Diniz
    PHARMACEUTICS, 2024, 16 (08)